Publikationen der AG Neuro-gliale Pharmakologie

Pub_links

• orcid.org

• researcher id

• researchgate

  ?

Ausgew?hlte Publikationen

• Di Benedetto B. Focus on Mitogen-Activated Kinase Phosphatase-1: Looking for the Roots of Depression in the Anterior Cingulate Cortex. Biol Psychiatry 2017; 82(5):e33-e34.
• Rupprecht R, Di Benedetto B. Extracellular Signal-Regulated Kinases: A Role for Mood Disorders and the Emotional Component of Pain? Biol Psychiatry 2017; 81(8):639-641.
• Di Benedetto B. Ephrins in astrocytes: synaptic erasers on stage. Oncotarget 2017;8(4):5676-5677.
• Tanasic S, Mattusch C, Wagner EM, Eder M, Rupprecht R, Rammes G, Di Benedetto B. Desipramine targets astrocytes to attenuate synaptic plasticity via modulation of the ephrinA3/EphA4 signalling. Neuropharmacology 2016; 105: 154-163.
• Di Benedetto B, Malik VA, Begum S, Jablonowski L, Gómez-González GB, Neumann ID, et al. Fluoxetine requires the endfeet protein aquaporin-4 to enhance plasticity of astrocyte processes. Frontiers in Cellular Neuroscience 2016; 10.
• Jakovcevski M, Akbarian S, Di Benedetto B. “Pharmacological modulation of astrocytes and the role of cell type-specific histone modifications for the treatment of mood disorders.”. Curr Opin Pharmacol. 2015 Oct 23;26:61-66. doi: 10.1016/j.coph.2015.10.002. [Epub ahead of print].
• Di Benedetto B, Rupprecht R and Czeh B. “Talking to the synapse: how antidepressants can target glial cells to reshape brain circuits”. Curr Drug Targets. 2013 Oct;14(11):1329-35.
• Di Benedetto B and Rupprecht R. “Targeting glia cells: novel perspectives for the treatment of neuropsychiatric diseases”. Current Neuropharmacology. 2013 Mar;11(2):171-85 - Invited contribution.
• Di Benedetto B, Radecke J, Schmidt MV, Rupprecht R. “Acute antidepressant treatment differently modulates ERK/MAPK activation in neurons and astrocytes in the adult mouse prefrontal cortex”. Neuroscience. 2013 Mar 1;232:161-8.

• Czéh B and Di Benedetto B. “Antidepressants act on astrocytes: evidence and functional implications”. Eur Neuropsychopharmacol. 2013 Mar;23(3):171-85.
• Di Benedetto B, Kühn R, Nothdurfter C, Rein T, Wurst W, and Rupprecht R. “N-desalkylquetiapine Activates ERK1/2 to Induce GDNF Release in C6 Glioma Cells: a Putative Cellular Mechanism for Quetiapine as Antidepressant”. Neuropharmacology. 2012 Jan;62(1):209-16 – invited contribution for the Special Issue “Anxiety and depression”.
• Di Benedetto B, Wefers B, Wurst W and Kühn R. “Local Knockdown of ERK2 in the Adult Mouse Brain Via Adeno-Associated Virus-Mediated RNA Interference”. Mol Biotechnol. 2009 Mar;41(3):263-9.
• Di Benedetto B, Kallnik M, Weisenhorn DM, Falls WA, Wurst W and H?lter SM. “Activation of ERK/MAPK in the lateral amygdala of the mouse is required for acquisition of a Fear Potentiated Startle response”. Neuropsychopharmacology. 2009 Jan;34(2):356-66. [Epub 2008 Apr 23].
• Di Benedetto B, Hitz C, H?lter SM, Kühn R, Vogt Weisenhorn DM and Wurst W. “Differential mRNA Distribution of Components of the ERK/MAPK Signalling Cascade in the Adult Mouse Brain”. J Comp Neurol. 2007 Jan 20; 500 (3): 542-556.
• Muzio L, Di Benedetto B, Stoykova A, Boncinelli E, Gruss P, Mallamaci A. “Conversion of cerebral cortex into basal ganglia in Emx2(-/-) Pax6(Sey/Sey) double-mutant mice”. Nat Neurosci. 2002 Aug; 5(8):737-45.
• Muzio L, Di Benedetto B, Stoykova A, Boncinelli E, Gruss P, Mallamaci A. “Emx2 and Pax6 control regionalization of the pre-neuronogenic cortical primordium”. Cereb Cortex. 2002 Feb; 12(2):129-39.